1 year return (CAGR)
-
Polaryx Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
PLYX
2.15
+0.01 (+0.47%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
107.17M
Price/Sales
-
Ent value
96.50M
Price/Book
9.80
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 2.11 |
| Daily high | 2.15 |
| Daily low | 2.09 |
| Daily Volume | 25K |
| All-time high | 35.00 |
| 1y analyst estimate | 7.50 |
| Beta | - |
| EPS (TTM) | -0.14 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| PLYX | S&P500 | |
| Current price drop from All-time high | -93.86% | -0.58% |
| Highest price drop | -94.66% | -56.47% |
| Date of highest drop | 24 Aug 2026 | 9 Mar 2009 |
| Avg drop from high | -88.18% | -10.68% |
| Avg time to new high | 81 days | 12 days |
| Max time to new high | 161 days | 1805 days |
